Core Scientific, Inc.
CORZR- Exchange
- OTC
- Industry
- Finance Services
- SEC CIK
- 0001839341
In the last 90 days, Core Scientific, Inc. insiders filed 3 open-market purchases and 12 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Market capClose on Nov 9, 2026
- $4.10B
- Insider buysLast 90 days, $342.3K in total
- 3
- Insider sellsLast 90 days, $1.96M in total
- 12
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $319.0M
- −37.5% year over year
- Net income, FY2025
- -$288.6M
- No comparable prior period
- Free cash flow, FY2025
- -$450.8M
- No comparable prior period
- Revenue, Q3 FY2026
- $232.9M
- +187.1% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $288.6M (90.5% of revenue).
Superinvestors holding CORZR, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding CORZR at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Core Scientific, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 4, 2026 (view filing)4:21 PM ET | Nov 2 | 2 days | Duchene Todd MSee remarks | SSale | −10.0K | $12.78 | −$127.8K | −0.9%1.12M after | 2 lots10b5-1 |
| Oct 28, 2026 (view filing)4:18 PM ET | Oct 26 | 2 days | Duchene Todd MSee remarks | SSale | −10.0K | $13.56 | −$135.6K | −0.9%1.13M after | 2 lots10b5-1 |
| Oct 20, 2026 (view filing)4:05 PM ET | Oct 19 | 1 day | Duchene Todd MSee remarks | SSale | −10.0K | $13.87 | −$138.7K | −0.9%1.14M after | 10b5-1 |
| Oct 14, 2026 (view filing)4:07 PM ET | Oct 12 | 2 days | Duchene Todd MSee remarks | SSale | −10.0K | $15.12 | −$151.2K | −0.9%1.16M after | 10b5-1 |
| Oct 7, 2026 (view filing)4:50 PM ET | Oct 5 | 2 days | Duchene Todd MSee remarks | SSale | −10.0K | $16.31 | −$163.1K | −0.8%1.17M after | 10b5-1 |
| Sep 30, 2026 (view filing)4:40 PM ET | Sep 28 | 2 days | Duchene Todd MSee remarks | SSale | −10.0K | $16.76 | −$167.6K | −0.8%1.19M after | 10b5-1 |
| Sep 23, 2026 (view filing)4:11 PM ET | Sep 21 | 2 days | Duchene Todd MSee remarks | SSale | −10.0K | $18.37 | −$183.7K | −0.8%1.20M after | 10b5-1 |
| Sep 17, 2026 (view filing)4:26 PM ET | Sep 15 | 2 days | Weiss Eric StantonDirector | PPurchase | +6.00K | $16.33 | +$98.0K | +2.3%265.3K after | |
| Sep 16, 2026 (view filing)4:01 PM ET | Sep 14 | 2 days | Duchene Todd MSee remarks | SSale | −10.0K | $17.14 | −$171.4K | −0.8%1.21M after | 10b5-1 |
| Sep 10, 2026 (view filing)4:08 PM ET | Sep 8 | 2 days | Duchene Todd MSee remarks | SSale | −10.0K | $18.67 | −$186.7K | −0.8%1.22M after | 10b5-1 |
Top 10 13F holders, Q2 2026
View all: Top 10 13F holders, Q2 2026The largest institutional positions in Core Scientific, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding CORZR in 13F filings for Q2 2026.